Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

106.78 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

2 Monster Stocks in the Making to Buy and Hold ↗

December 02, 2025

There's still time to get in on these rising stars.

Via The Motley Fool

1 Value Stock to Target This Week and 2 We Question

December 01, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion

December 01, 2025

As December 1, 2025, dawns, global financial markets are grappling with a significant uptick in Treasury yields, a movement primarily catalyzed by a substantial sell-off in Japanese government debt and...

Via MarketMinute

Topics Bonds Economy Stocks

Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices ↗

November 20, 2025

Via Stocktwits

Topics Workforce

Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study ↗

November 19, 2025

Via Stocktwits

Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications

December 01, 2025

New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global...

Via MarketMinute

Topics Bonds Credit Cards Economy

Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025

December 01, 2025

From Merck Sharp & Dohme

Via Business Wire

These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗

November 30, 2025

If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.

Via The Motley Fool

Topics Energy Intellectual Property

3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗

November 30, 2025

There are plenty of potential winners outside the world of AI.

Via The Motley Fool

Topics Artificial Intelligence

Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%? ↗

November 29, 2025

The struggling pharmaceutical giant is showing signs of life.

Via The Motley Fool

Dow Industrials Erase November Losses: A Beacon of Optimism Amidst Market Crossroads

November 28, 2025

The Dow Jones Industrial Average (DJIA) has staged a remarkable comeback, successfully erasing its November 2025 losses by the month's final trading day, Friday, November 28, 2025. This significant...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Merck & Co. Inc. (NYSE:MRK): A Dividend Stock with Strong Profitability and Financial Health ↗

November 28, 2025

Discover Merck (MRK), a top dividend stock with a 3.58% yield, strong growth history, and excellent profitability for reliable income.

Via Chartmill

Merck to Participate in the Citi 2025 Global Healthcare Conference

November 26, 2025

From Merck & Co., Inc.

Via Business Wire

Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference

November 26, 2025

From Merck Sharp & Dohme

Via Business Wire

Dow Jones Navigates Volatility Amidst AI Bubble Fears and Shifting Fed Expectations

November 25, 2025

The Dow Jones Industrial Average has been on a roller-coaster ride in November 2025, experiencing significant volatility and sending mixed signals across various sectors. While the index achieved a...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Stocks making big moves yesterday: Meta, Tenet Healthcare, Wynn Resorts, Elevance Health, and Merck

November 25, 2025

Check out the companies making headlines yesterday:

Via StockStory

Topics Artificial Intelligence

Why Merck (MRK) Stock Is Trading Up Today

November 24, 2025

Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells Fargo upgraded the stock to "Overweight" from "Equal-Weight," citing confidence in the...

Via StockStory

Topics Artificial Intelligence Economy

Biotech Valuations Rise as New Clinical Platforms Show Progress

November 24, 2025

Via Investor Brand Network

Biotech Valuations Rise as New Clinical Platforms Show Progress

November 24, 2025

From BioMedWire

Via GlobeNewswire

Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches

November 24, 2025

From Merck & Co., Inc.

Via Business Wire

Q3 Earnings Outperformers: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Stocks

November 23, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Merck (NYSE:MRK) and the best and worst...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Merck Recommends Rejection of Tutanota’s “Mini-Tender” Offer

November 21, 2025

From Merck & Co., Inc.

Via Business Wire

Mettler-Toledo, Agilent, Waters Corporation, Merck, and Regeneron Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy World Trade

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

November 21, 2025

From Merck & Co., Inc.

Via Business Wire

Goldman Sachs Just Delivered Bad News for U.S. Investors ... Sort Of. Here's What You Need to Know. ↗

November 21, 2025

The investment bank's analysts simply recognize how much has changed in just the past few years, and what that means for the near future.

Via The Motley Fool

Topics Artificial Intelligence Economy

Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs? ↗

November 20, 2025

The pharmaceutical giant's post-Keytruda plans continue to take shape.

Via The Motley Fool

Topics Intellectual Property

Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗

November 20, 2025

Shares in the biotech company have surged on news of a big pharma takeover.

Via The Motley Fool

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗

November 19, 2025

Via MarketBeat

Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment ↗

November 19, 2025

Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.

Via Benzinga

2 Healthcare Stocks Worth Your Attention and 1 We Ignore

November 19, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.